Pure Global

Contraceptive Efficacy Study of Ovaprene - Trial NCT06127199

Access comprehensive clinical trial information for NCT06127199 through Pure Global AI's free database. This phase not specified trial is sponsored by Daré Bioscience, Inc. and is currently Not yet recruiting. The study focuses on Contraception. Target enrollment is 656 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06127199
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06127199
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Contraceptive Efficacy Study of Ovaprene
A Single Arm, Open-Label Pivotal Contraceptive Efficacy Study of Ovaprene

Study Focus

Contraception

Ovaprene

Interventional

device

Sponsor & Location

Daré Bioscience, Inc.

Berkeley,Los Angeles,Sacramento,San Francisco,Aurora,Atlanta,Honolulu,Baltimore,Boston,Saint Louis,Newark,Bronx,New York,Cincinnati,Cleveland,Portland,Philadelphia,Pittsburgh,Salt Lake City,Norfolk, United States of America

Timeline & Enrollment

N/A

Dec 01, 2023

Sep 01, 2025

656 participants

Primary Outcome

Determination of pregnancy rate

Summary

This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal
 intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability
 of Ovaprene.

ICD-10 Classifications

Contraceptive management
Oral contraceptives
Other contraceptive management
General counselling and advice on contraception
Personal history of contraception

Data Source

ClinicalTrials.gov

NCT06127199

Device Trial